Stamaril Stungulyfsstofn og leysir, dreifa Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

stamaril stungulyfsstofn og leysir, dreifa

sanofi pasteur* - gulusóttarveira 17d-204 stofn (lifandi, veikluð) - stungulyfsstofn og leysir, dreifa

Engerix B Stungulyf, dreifa Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

engerix b stungulyf, dreifa

glaxosmithkline pharma a/s - lifrarbólgu b yfirborðsmótefnavaki - stungulyf, dreifa

Boostrix Stungulyf, dreifa áfyllt sprauta Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

boostrix stungulyf, dreifa áfyllt sprauta

glaxosmithkline pharma a/s - pertussis toxoid; filamentous haemagglutinin; pertactin; diphtheria toxoid; tetanus toxoid - stungulyf, dreifa - áfyllt sprauta

Boostrix Polio Stungulyf, dreifa áfyllt sprauta Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

boostrix polio stungulyf, dreifa áfyllt sprauta

glaxosmithkline pharma a/s - diphtheria toxoid; tetanus toxoid; pertussis toxoid; filamentous haemagglutinin; pertactin; poliovirus inactivated type 1; poliovirus inactivated type 2; poliovirus inactivated type 3 - stungulyf, dreifa - áfyllt sprauta

Pneumovax Stungulyf, lausn í áfylltri sprautu 25 míkróg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

pneumovax stungulyf, lausn í áfylltri sprautu 25 míkróg

merck sharp & dohme b.v. - pneumococcal polysaccharide danish types 1,2,3,4,5,6b,7f,8,9n,9v,10a,11a,12f,14,15b,17f,18,c,19a, 19f,20,22f,23f,33f - stungulyf, lausn í áfylltri sprautu - 25 míkróg

Varivax Stungulyfsstofn og leysir, dreifa Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

varivax stungulyfsstofn og leysir, dreifa

merck sharp & dohme b.v.* - varicella virus oka/merck strain, (live, attenuated) produced in human diploid (mrc-5) cells - stungulyfsstofn og leysir, dreifa

VaxigripTetra Stungulyf, dreifa í áfylltri sprautu 15 míkróg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

vaxigriptetra stungulyf, dreifa í áfylltri sprautu 15 míkróg

sanofi pasteur* - a/victoria/2570/2019 (h1n1)pdm09 - líkur stofn (a/victoria/2570/2019, ivr-215); a/darwin/9/2021 (h3n2) - líkur stofn (a/darwin/9/2021, ivr-228); b/austria/1359417/2021 - líkur stofn (b/michigan/01/2021, villigerð); b/phuket/3073/2013-líkur stofn (b/phuket/3073/2013, villigerð) - stungulyf, dreifa í áfylltri sprautu - 15 míkróg

Zoonotic Influenza Vaccine Seqirus Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

zoonotic influenza vaccine seqirus

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - bóluefni - active immunisation against h5 subtype of influenza a virus.